ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MTFB Motif Bio Plc

0.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.55 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Motif Bio PLC Exercise of Warrants (2659B)

08/01/2018 3:23pm

UK Regulatory


Motif Bio (LSE:MTFB)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Motif Bio Charts.

TIDMMTFB

RNS Number : 2659B

Motif Bio PLC

08 January 2018

Motif Bio plc

("Motif Bio" or the "Company")

Exercise of Warrants

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that it has received notification from a warrant holder to exercise warrants representing 471,602 ordinary shares of 1p each ("Ordinary Shares") in the Company at an exercise price of 20.0p per warrant for total consideration of GBP94,320.40.

Application has been made for the 471,602 new Ordinary Shares to be admitted to trading on AIM ("Admission"), which is expected to occur at 8.00 a.m. on January 11, 2018. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Following Admission, and for the purposes of the Disclosure Guidance and Transparency Rules, the Company's total issued share capital will consist of 263,990,730 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company.

For further information, please contact:

 
 Motif Bio plc                                                                        info@motifbio.com 
 Graham Lumsden (Chief 
  Executive Officer) 
 Robert Dickey IV (Chief 
  Financial Officer) 
 
 Peel Hunt LLP (NOMAD 
  & BROKER)                                                                        + 44 (0)20 7418 8900 
 Dr Christopher Golden 
 Oliver Jackson 
 
 Northland Capital Partners 
  Limited (BROKER)                                                                  +44 (0)203 861 6625 
 Patrick Claridge/ David 
  Hignell 
 John Howes/ Rob Rees 
  (Broking) 
 
 Walbrook PR Ltd.                                       +44 (0) 20 7933 8780 or motifbio@walbrookpr.com 
  (FINANCIAL PR & IR) 
 Paul McManus/Helen Cresswell/Lianne 
  Cawthorne 
 
 MC Services AG (EUROPEAN 
  IR)                                                                                +49 (0)89 210 2280 
 Raimund Gabriel                                                         raimund.gabriel@mc-services.eu 
 
 
 The Trout Group (US                                                                 + 1 (646) 378-2936 
  IR) 
 Meggie Purcell                                                                 mpurcell@troutgroup.com 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSSWFIAFASESF

(END) Dow Jones Newswires

January 08, 2018 10:23 ET (15:23 GMT)

1 Year Motif Bio Chart

1 Year Motif Bio Chart

1 Month Motif Bio Chart

1 Month Motif Bio Chart

Your Recent History

Delayed Upgrade Clock